UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.20 -2.73 (-3.33%) GOLD FUTURES
2,312.10 +9.20 (+0.40%) DOW
37,969.41 +153.49 (+0.41%) Bitcoin GBP
45,813.66 -2,457.34 (-5.09%)
Nuvectis Pharma, Inc. (NVCT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:32PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 108.57M |
| Enterprise value | 89.44M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 8.90 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.91 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.27 |
| 52-week change 3 | -57.57% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 18.65 |
| 52-week low 3 | 5.92 |
| 50-day moving average 3 | 8.31 |
| 200-day moving average 3 | 10.05 |
Share statistics
| Avg vol (3-month) 3 | 97.04k |
| Avg vol (10-day) 3 | 70.94k |
| Shares outstanding 5 | 17.77M |
| Implied shares outstanding 6 | 17.77M |
| Float 8 | 5.11M |
| % held by insiders 1 | 55.33% |
| % held by institutions 1 | 16.53% |
| Shares short (15 Apr 2024) 4 | 822.55k |
| Short ratio (15 Apr 2024) 4 | 9.59 |
| Short % of float (15 Apr 2024) 4 | 8.93% |
| Short % of shares outstanding (15 Apr 2024) 4 | 4.63% |
| Shares short (prior month 15 Mar 2024) 4 | 766.09k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -69.14% |
| Return on equity (ttm) | -168.51% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -22.26M |
| Diluted EPS (ttm) | -1.43 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 19.13M |
| Total cash per share (mrq) | 1.08 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.75 |
| Book value per share (mrq) | 0.70 |
Cash flow statement
| Operating cash flow (ttm) | -15.95M |
| Levered free cash flow (ttm) | -7.83M |
© 2024 Yahoo. All rights reserved.